IL6R and metabolic dysfunction-associated steatotic liver disease: Although a previous study found increased concentrations the sIL-6R and sTNFR1 in NAFLD patients compared with healthy volunteers [45], this is the first study investigating these 3 receptors in different stages of NAFLD.